Goosby Says PEPFAR Remains Among 'Highest Priorities' Of Obama Administration, Welcomes Partnership With South African President Zuma
Main Category: HIV / AIDSArticle Date: 20 Nov 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Eric Goosby, head of PEPFAR, on Wednesday reemphasized the U.S. commitment to fighting HIV/AIDS globally, the Associated Press reports. Despite concerns by international aid groups that the current economic climate might force HIV/AIDS funding to be scaled back, "Goosby said President Barack Obama and Secretary of State Hillary Rodham Clinton have assured him his program remains among 'the highest priorities,'" the news service writes.
Goosby's comments came during a telephone interview from Washington, where he "also described a new era of cooperation with South Africa, the nation that bears the greatest AIDS burden" and is also "the largest recipient of PEPFAR funds," according to the AP. "We are very gratified to be able to partner with the Zuma administration in a much more robust manner," Goosby said.
According to Mary Fanning, head of health programs at the U.S. Embassy in Pretoria, South Africa, PEPFAR's budget for the country was set to get a $10 million increase for 2010-2011 from the previous year. Fanning said the U.S. seeks to help the country meet its goals in the fight against HIV/AIDS and "in an unprecedented move … left 5 percent of next year's budget free to be used as the South African government saw fit," the AP writes (Bryson, 11/18).
This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/171651.php>
APA
http://www.medicalnewstoday.com/releases/171651.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



